TKTae Young Kim

Tae Young Kim

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Tae Young Kim has a total of 70 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Synergistic Mechano‐Fluidic Self‐Fusion of Poly(Vinyl Alcohol)‐Modified Liquid‐Metal Particles for Post‐Treatment‐Free Soft Electronics

    by Keun‐Young Yook, Sangwon Kim, Chansoo Kim, Minkyong Kang, Yurim Lee, Mido Kim, Kijun Park, Seung Yeop Han, Seung‐Woo Cho, Gun‐Hee Lee, et al.

    Liquid metals (LMs) are promising candidates for soft and stretchable conductors; however, their high surface tension and poor wettability pose significant challenges for high‐resolution printing. To address these limitations, LMs are commonly processed into liquid metal particles (LMPs), which improve printability. Nevertheless, the insulating oxide shell surrounding each particle persists, typically necessitating additional post‐treatment steps to achieve electrical conductivity. Here, we report synergistic mechano‐fluidic self‐fusion of poly(vinyl alcohol) (PVA)‐modified liquid‐metal particles (PmLMPs) for post‐treatment‐free soft interconnects. A sprayable PmLMP ink is formulated in which an ultrathin PVA shell stabilizes the particles and enhances substrate adhesion through hydrogen bonding. Direct electrical interconnection is achieved via a two‐stage process: spray‐induced mechanical impact ruptures the oxide shells to initiate metallic contact, followed by binary‐solvent‐driven Marangoni convection (deionized (DI) water/ethanol = 3:1 v/v) that promotes particle rearrangement and metallic neck growth. This mechano‐fluidic sequence enables rapid formation of conductive networks without post‐treatment. The printed films exhibit an initial conductivity of 1.5 × 10 6 S m − 1 , maintain electrical continuity under monotonic strains exceeding 200% and during approximately 1,400 stretch‐release cycles at 100% strain, and support 50 µm‐scale patterning with large‐area scalability. This work establishes a flow‐assisted metallic fusion approach for scalable, instantly conductive soft interconnects.

  • Open Access

    Bioadaptive liquid-infused multifunctional fibers for long-term neural recording via BDNF stabilization and enhanced neural interaction

    by Tae Young Kim, Yeonzu Son, Keun-Young Yook, Dong Gyu Lee, Young Kim, Seo Jung Kim, Kijun Park, Yurim Lee, Tae Kyung Lee, Justin J. Chung, et al.

    Brain-computer interfaces (BCIs) enable direct communication between the brain and computers. However, their long-term functionality remains limited due to signal degradation caused by acute insertion trauma, chronic foreign body reaction (FBR), and biofouling at the device-tissue interface. To address these challenges, we introduce a multifunctional surface modification strategy called targeting-specific interaction and blocking nonspecific adhesion (TAB) coating for flexible fiber, achieving a synergistic integration of mechanical compliance and biochemical stability. The coating combines brain-derived neurotrophic factor (BDNF) conjugation and a lubricant-infused surface. This dual-functional design enables selective interaction with neurons and astrocytes while preventing nonspecific adhesion. Notably, high-quality single-unit neural signals were stably recorded for more than 12 months after implantation, demonstrating exceptional long-term recording performance. Integrating mechanical compatibility, antifouling properties, and selective neural cell interaction, the TAB-coated multifunctional fiber represents a transformative approach for neural implants, bridging biological systems with computational systems.


  • Top Cited Papers
    Open Access

    A Mechanically Resilient and Tissue‐Conformable Hydrogel with Hemostatic and Antibacterial Capabilities for Wound Care

    by Jae Park, Tae Young Kim, Yeonju Kim, Soohwan An, Kyeong Seok Kim, Minkyong Kang, Soo A Kim, Jayoung Kim, Joonseok Lee, Seung‐Woo Cho, et al.

    Hydrogels are used in wound dressings because of their tissue‐like softness and biocompatibility. However, the clinical translation of hydrogels remains challenging because of their long‐term stability, water swellability, and poor tissue adhesiveness. Here, tannic acid (TA) is introduced into a double network (DN) hydrogel consisting of poly(vinyl alcohol) (PVA) and poly(acrylic acid) (PAA) to realize a tough, self‐healable, nonswellable, conformally tissue‐adhesive, hemostatic, and antibacterial hydrogel. The TA within the DN hydrogel forms a dynamic network, enabling rapid self‐healing (within 5 min) and offering effective energy dissipation for toughness and viscoelasticity. Furthermore, the hydrophobic moieties of TA provide a water‐shielding effect, rendering the hydrogel nonswellable. A simple chemical modification to the hydrogel further strengthens its interfacial adhesion with tissues (shear strength of ≈31 kPa). Interestingly, the TA also can serve as an effective hemostatic (blood‐clotting index of 58.40 ± 1.5) and antibacterial component, which are required for a successful wound dressing. The antibacterial effects of the hydrogel are tested against Escherichia coli and Staphylococcus aureus. Finally, the hydrogel is prepared in patch form and applied to a mouse model to test in vivo biocompatibility and hemostatic performances.


  • Open Access

    Sprayable nanomicelle hydrogels and inflammatory bowel disease patient cell chips for development of intestinal lesion-specific therapy

    by Hyo-Jin Yoon, Songhyun Lee, Tae Young Kim, Seung Eun Yu, Hye-Seon Kim, Young Shin Chung, Seyong Chung, Suji Park, Yong Cheol Shin, Eun Kyung Wang, et al.

    All-in-one treatments represent a paradigm shift in future medicine. For example, inflammatory bowel disease (IBD) is mainly diagnosed by endoscopy, which could be applied for not only on-site monitoring but also the intestinal lesion-targeted spray of injectable hydrogels. Furthermore, molecular conjugation to the hydrogels would program both lesion-specific adhesion and drug-free therapy. This study validated this concept of all-in-one treatment by first utilizing a well-known injectable hydrogel that underwent efficient solution-to-gel transition and nanomicelle formation as a translatable component. These properties enabled spraying of the hydrogel onto the intestinal walls during endoscopy. Next, peptide conjugation to the hydrogel guided endoscopic monitoring of IBD progress upon adhesive gelation with subsequent moisturization of inflammatory lesions, specifically by nanomicelles. The peptide was designed to mimic the major component that mediates intestinal interaction with Bacillus subtilis flagellin during IBD initiation. Hence, the peptide-guided efficient adhesion of the hydrogel nanomicelles onto Toll-like receptor 5 (TLR5) as the main target of flagellin binding and Notch-1. The peptide binding potently suppressed inflammatory signaling without drug loading, where TLR5 and Notch-1 operated collaboratively through downstream actions of tumor necrosis factor-alpha. The results were produced using a human colorectal cell line, clinical IBD patient cells, gut-on-a-chip, a mouse IBD model, and pig experiments to validate the translational utility.


  • Serum glucose excretion after Roux-en-Y gastric bypass: a potential target for diabetes treatment

    by In Gyu Kwon, Chan Woo Kang, Jong-Pil Park, Ju Hun Oh, Eun Kyung Wang, Tae Young Kim, Jin Sol Sung, Namhee Park, Yang Jong Lee, Hak-Joon Sung, et al.

    Objective: The mechanisms underlying type 2 diabetes resolution after Roux-en-Y gastric bypass (RYGB) are unclear. We suspected that glucose excretion may occur in the small bowel based on observations in humans. The aim of this study was to evaluate the mechanisms underlying serum glucose excretion in the small intestine and its contribution to glucose homeostasis after bariatric surgery. Design: 2-Deoxy-2-[ 18 F]-fluoro-D-glucose (FDG) was measured in RYGB-operated or sham-operated obese diabetic rats. Altered glucose metabolism was targeted and RNA sequencing was performed in areas of high or low FDG uptake in the ileum or common limb. Intestinal glucose metabolism and excretion were confirmed using 14 C-glucose and FDG. Increased glucose metabolism was evaluated in IEC-18 cells and mouse intestinal organoids. Obese or ob/ob mice were treated with amphiregulin (AREG) to correlate intestinal glycolysis changes with changes in serum glucose homeostasis. Results: The AREG/EGFR/mTOR/AKT/GLUT1 signal transduction pathway was activated in areas of increased glycolysis and intestinal glucose excretion in RYGB-operated rats. Intraluminal GLUT1 inhibitor administration offset improved glucose homeostasis in RYGB-operated rats. AREG-induced signal transduction pathway was confirmed using IEC-18 cells and mouse organoids, resulting in a greater capacity for glucose uptake via GLUT1 overexpression and sequestration in apical and basolateral membranes. Systemic and local AREG administration increased GLUT1 expression and small intestinal membrane translocation and prevented hyperglycaemic exacerbation. Conclusion: Bariatric surgery or AREG administration induces apical and basolateral membrane GLUT1 expression in the small intestinal enterocytes, resulting in increased serum glucose excretion in the gut lumen. Our findings suggest a novel, potentially targetable glucose homeostatic mechanism in the small intestine.


  • External Self‐Closing Tube to Occlude a Vessel Gradually as a Therapeutic Means of Portosystemic Shunt

    by Tae Young Kim, Dae‐Hyun Kim, Jeong‐Kee Yoon, Surim Kim, Se Won Yi, Won Taek Oh, Ju Young Park, Hye‐Seon Kim, Mi‐Lan Kang, Jung Bok Lee, et al.

    The vascular network to the liver can be connected abnormally during fetal development (e.g., portosystemic shunt), thus requiring a device to close the flow connection completely. Gradual vascular occlusion is particularly important, because a sudden stop in blood flow can result in portal hypertension and cause consequential damage to the small intestine. Significant progress has been made in the development of such devices (e.g., the ameroid ring constrictor and cellophane banding) as a standard treatment for this disorder. However, incomplete occlusion is a common problem. In this study, a new vascular occlusion device is developed, enabling two major functions. First, user‐friendly deployment onto the external vascular wall is achieved by programming a recovery in the shape of the tube from open to closed in response to treatment with a warm saline solution (37 °C). Second, proinflammatory palmitic acid is released over time from the tube surface through the adventitial wall to induce gradual occlusive vascular remodeling. These unprecedented functions are demonstrated in a series of experiments on cells and rabbit veins, addressing this major issue through gradual but complete vascular occlusion over time. The external self‐closing tube represents a breakthrough proof‐of‐concept for treatment of this rare but critical developmental disorder.